Association Between Sensorineural Hearing Loss and Various Stages of Chronic Kidney Disease

Abstract

Objectives To compare the proportion of sensorineural hearing impairment (SHI) among patients of chronic kidney disease (CKD) stages 3&4 with CKD stage 5.

Materials and Methods This is a cross-sectional study of 30 patients with CKD stages 3 and 4 and 30 patients in stage 5. All patients had an audiological evaluation with pure tone audiometry.

Results Our study had 49 males (82%) and 11 females (18%), with the age ranging from 20 to 60 years (mean: 45.13 years). The mean SHI values in stage 3&4 were 28.44 dB and in CKD stage 5 was 31.22 dB. In the right ear, the mean hearing loss in stage 3, stage 4, and stage 5 was 28.17 dB, 28.67 dB, and 31.84 dB, respectively. In the left ear, the mean SHI values in stage 3, stage 4, and stage 5 were 27.05 dB, 31.89 dB, and 30.61 dB, respectively.

The mean SHI in stage 3&4 for age group 20 to 30 years was 13.66 dB, for 31 to 40 years was 26.33 dB, for 41 to 50 years was 35.18 dB, for 51 to 60 years was 37.12 dB. The mean SHI in stage 5 for the age group of 20 to 30 years was 16.48 dB, for 31 to 40 years was 28.29 dB, for 41 to 50 years was 31.82 dB, for 51 to 60 years was 34.35 dB. There was a significant correlation between hearing loss and CKD with respect to age (p < 0.001). The duration of renal illness and associated comorbidities was not a significant contributor to hearing loss in our study (p > 0.05).

Conclusion As per our study, with progression in the stage of chronic kidney disease, the hearing loss also increased indicating a possible link between the two. We also noted that the hearing loss increased with the increasing age.

Keywords

chronic kidney disease - pure tone audiometry - sensorineural hearing impairment

Publikationsverlauf

Artikel online veröffentlicht:
31. Dezember 2021

• References

• 1 Quick CA, Fish A, Brown C. The relationship between cochlea and kidney. Laryngoscope 1973; 83 (09) 1469-1482
• 2 Arnold W. Inner ear and renal diseases. Ann Otol Rhinol Laryngol Suppl 1984; 112: 119-124
• 3 Ronco C, Bellomo R. Renal replacement methods in acute renal failure. . Edited by: Davison AM, Cameron JS, Grunfeld JP; Kerr DNS, Ritz E, Winearls CG. Oxford Textbook of Clinical Nephrology; 1998. 2. 1583-1607
• 4 Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG. Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med 2003; 348 (25) 2543-2556
• 5 Kochhar A, Fischer SM, Kimberling WJ, Smith RJ. Branchio-oto-renal syndrome. Am J Med Genet A 2007; 143A (14) 1671-1678
• 6 Zarate YA, Hopkin RJ. Fabry's disease. Lancet 2008; 372 (9647): 1427-1435
• 7 Van Esch H, Groenen P, Nesbit MA. et al. GATA3 haplo-insufficiency causes human HDR syndrome. Nature 2000; 406 (6794): 419-422
• 8 Fauci. Harrisons principles of internal medicine. 17th ed. McGraw hill; 2008: 2200-2211
• 9 Bergstrom L, Jenkins P, Sando I, English GM. Hearing loss in renal disease: clinical and pathological studies. Ann Otol Rhinol Laryngol 1973; 82 (04) 555-576
• 10 Kusakari J, Kobayashi T, Rokugo M. et al. The inner ear dysfunction in hemodialysis patients. Tohoku J Exp Med 1981; 135 (04) 359-369
• 11 Zeigelboim BS, Mangabeira-Albernaz PL, Fukuda Y. High frequency audiometry and chronic renal failure. Acta Otolaryngol 2001; 121 (02) 245-248
• 12 Meena RS, Aseri Y, Singh BK, Verma PC. Hearing loss in patients of chronic renal failure: a study of 100 cases. Indian J Otolaryngol Head Neck Surg 2012; 64 (04) 356-359
• 13 Jamaldeen J, Basheer A, Sarma AC, Kandasamy R. Prevalence and patterns of hearing loss among chronic kidney disease patients undergoing haemodialysis. Australas Med J 2015; 8 (02) 41-46
• 14 Reddy EK, Surya Prakash DR, Rama Krishna MGKD. Proportion of hearing loss in chronic renal failure: our experience. Indian Journal of Otology. 2016; 2: 4-9
• 15 Rahman R, Akhtar N. The prevalence of hearing loss in chronic kidney disease Bangladeshi patients undergoing dialysis. Glob J Med Res 2016; 16 (04) 19-22